SS

Shitalben Sanjykumar Modi

Active Director Director DIN 01725110
DIN 01725110 First appointment Mar 2003 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 7 active board seats
Total affiliations 7 Since Mar 2003
Shareholding value •••• Premium profile

About Shitalben Sanjykumar Modi

Data last updated:

Shitalben Sanjykumar Modi is a Director at Lustre Pharmaceuticals Private Limited (since 2003), Director at Sarathi Super Structure Private Limited (since 2017) and Director at Sarathi Multispeciality Hospital Private Limited (since 2012), and holds 4 more current directorships. The companies operate in Pharma, Infrastructure and Utilities and Healthcare. The 4 current companies with reported revenue have a combined latest revenue of ₹12.06 Cr; the largest is Lustre Pharmaceuticals Private Limited at ₹10.03 Cr (FY 2025).

DIN 01725110
Primary Designation Director
Industry Pharma
First Appointment 24 Mar 2003
Oldest Company Age 23 yrs
Largest company Lustre Pharmaceuticals Private Limited · ₹10.03 Cr (FY 2025)
Combined revenue ₹12.06 Cr across 4 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director24 Mar 20032003₹10.03 Cr (FY 2025)Active
Director27 Jun 20172017₹1.03 Cr (FY 2025)Active
Director30 May 20122012₹89.2 Lakh (FY 2025)Active
Designated Partner23 Apr 20182018₹10.4 Lakh (FY 2021)Active
Designated Partner10 Jan 20252023Active
Vibrantunity Llp ACK-7960
Designated Partner12 Dec 20242024Active
Designated Partner20 Sep 20242024Active

Directorship timeline

Open interactive timeline →
Lustre Pharmaceuticals Private Limited
Sarathi Super Structure Private Limited
Sarathi Multispeciality Hospital Private Limited
Lustre Energy Llp
Premium access

Shareholding and investment profile for Shitalben Sanjykumar Modi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Shitalben Sanjykumar Modi

Shitalben Sanjykumar Modi currently holds 7 directorships: Lustre Pharmaceuticals Private Limited (Director, since 24 Mar 2003, revenue ₹10.03 Cr (FY 2025)); Sarathi Super Structure Private Limited (Director, since 27 Jun 2017, revenue ₹1.03 Cr (FY 2025)); Sarathi Multispeciality Hospital Private Limited (Director, since 30 May 2012, revenue ₹89.2 Lakh (FY 2025)); Lustre Energy Llp (Designated Partner, since 23 Apr 2018, revenue ₹10.4 Lakh (FY 2021)); Shree Shivgiriji Industries Llp (Designated Partner, since 10 Jan 2025); and 2 more.

Shitalben Sanjykumar Modi was first appointed on 24 Mar 2003 as Director at Lustre Pharmaceuticals Private Limited. The most recent appointment on record is 10 Jan 2025 at Shree Shivgiriji Industries Llp.

The 4 current companies of Shitalben Sanjykumar Modi that report revenue have a combined latest revenue of ₹12.06 Cr: Lustre Pharmaceuticals Private Limited ₹10.03 Cr (FY 2025); Sarathi Super Structure Private Limited ₹1.03 Cr (FY 2025); Sarathi Multispeciality Hospital Private Limited ₹89.2 Lakh (FY 2025); Lustre Energy Llp ₹10.4 Lakh (FY 2021).

The current boards of Shitalben Sanjykumar Modi's companies include Hirenkumar Knatilal Modi (Lustre Pharmaceuticals Private Limited), Jatinkumar Kantilal Modi (Lustre Pharmaceuticals Private Limited), Sanjaykumar Babulal Modi (Lustre Pharmaceuticals Private Limited), Amin Hajimohmad Manjiyani (Sarathi Super Structure Private Limited), Nachiket Sanjaykumar Modi (Sarathi Super Structure Private Limited), Hemrajbhai Rana (Vibrantunity Llp), among others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available